AbbVie (ABBV) Cash & Current Investments (2012 - 2026)
AbbVie's Cash & Current Investments came in at $6.57 billion for Q2 2026, up 1.6% from $6.47 billion a year earlier but down 30.1% from the prior quarter.
AbbVie (ABBV) Cash & Current Investments (2012 - 2026) Analysis & Trends
At the end of FY2025, AbbVie's Cash & Current Investments was $5.26 billion, down 5.4% from FY2024.
- Cash & Current Investments carries a five-year compound annual growth rate of -9.1% (FY2020 to FY2025).
- Going back by year, Cash & Current Investments was $5.56 billion in FY2024 (-56.7%), $12.82 billion in FY2023 (+38.9%), $9.23 billion in FY2022 (-6.1%) and $9.83 billion in FY2021 (+15.9%).
- The five-year range for quarterly Cash & Current Investments is $5.18 billion (Q1 2025) to $18.07 billion (Q1 2024).
- Year-over-year, Cash & Current Investments increased in two of the last eight quarters, with an average decline of 21.1%.
- The fastest year-over-year change in Cash & Current Investments over five years came in Q1 2024 (growth of 168.8%), and the weakest in Q1 2025 (a decline of 71.4%).
- Business Quant data shows ABBV's Cash & Current Investments at $9.39 billion (Q1 2026), $5.26 billion (Q4 2025) and $5.67 billion (Q3 2025) in the three quarters before Q2 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,122.91 Bn | 1,091.50 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 615.09 Bn | 533.62 Bn | 17.26 Bn | 20.76 Bn |
| 3 | AbbVie | 504.75 Bn | 477.86 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 360.18 Bn | 314.55 Bn | 12.21 Bn | 7.14 Bn |
| 5 | Novartis Ag | 292.05 Bn | 256.04 Bn | 11.24 Bn | 7.69 Bn |
| 6 | Astrazeneca | 256.09 Bn | 229.78 Bn | 12.86 Bn | 4.90 Bn |
| 7 | Amgen | 233.63 Bn | 189.02 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 194.49 Bn | 168.69 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 168.35 Bn | 114.99 Bn | 10.94 Bn | 11.70 Bn |
| 10 | Vertex Pharmaceuticals | 126.70 Bn | 98.70 Bn | 2.84 Bn | 7.85 Bn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6.57 Bn |
| Mar 31, 2026 | 9.39 Bn |
| Dec 31, 2025 | 5.26 Bn |
| Sep 30, 2025 | 5.67 Bn |
| Jun 30, 2025 | 6.47 Bn |
| Mar 31, 2025 | 5.18 Bn |
| Dec 31, 2024 | 5.56 Bn |
| Sep 30, 2024 | 7.29 Bn |
| Jun 30, 2024 | 13.16 Bn |
| Mar 31, 2024 | 18.07 Bn |
| Dec 31, 2023 | 12.82 Bn |
| Sep 30, 2023 | 13.29 Bn |
| Jun 30, 2023 | 8.77 Bn |
| Mar 31, 2023 | 6.72 Bn |
| Dec 31, 2022 | 9.23 Bn |
| Sep 30, 2022 | 11.88 Bn |
| Jun 30, 2022 | 9.96 Bn |
| Mar 31, 2022 | 7.57 Bn |
| Dec 31, 2021 | 9.83 Bn |
| Sep 30, 2021 | 12.25 Bn |
AbbVie Cash & Current Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=ABBV&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-current-investments", "ticker": "ABBV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=ABBV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();